Dove, D., Warren, Z., McPheeters, M.L., Taylor, J.L., Sathe, N.A., & Veenstra-Vanderweele, J. (2012). Medications for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130(4), 717-726. doi: 10.1542/peds.2012-0683.
Fung, L.K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., Coury, D., Whitaker, A., Veenstra-Vanderweele, J., & Hardan, A.Y. (2016). Pharmacologic treatment of severe irritability and problem behaviors in autism: A systematic review and meta-analysis. Pediatrics, 137(Suppl.), 24-35. doi: 10.1542/peds.2015-2851K
Hazell, P. (2007). Drug therapy for attention deficit/hyperactivity disorder-like symptoms in autistic disorder. Journal of Paediatrics and Child Health, 43, 19-24. doi: 10.1111/j.1440-1754.2007.00995.x.
McPheeters, M.L., Warren, Z., Sathe, N., Bruzek, J.L., Krishnaswami, S., Jerome, R.N., & Veenstra-Vanderweele, J. (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 127(5), 1312-1321. doi: 10.1542/peds.2011-0427.
National Autism Center (2015). Findings and conclusions: National standards project, phase 2. Randolph, MA: National Autism Center. Retrieved 26 September 2016 from http://www.nationalautismcenter.org/national-standards-project/results-reports/.
Prior, M., & Roberts, J. (2012). Early intervention for children with autism spectrum disorders: Guidelines for good practice. Canberra: Australian Government Department of Social Services. Retrieved 23 June 2016 from https://www.dss.gov.au/our-responsibilities/disability-and-carers/program-services/for-people-with-disability/early-intervention-for-children-with-autism-spectrum-disorders-guidelines-for-good-practice-2012.
Prior, M., Roberts, J.M., Rodger, S., Williams, K., & Sutherland, R. (2011). A review of the research to identify the most effective models of practice in early intervention for children with autism spectrum disorders. Canberra: Australian Government Department of Families, Housing, Community Services and Indigenous Affairs. Retrieved 26 September 2016 from https://www.dss.gov.au/sites/default/files/documents/10_2014/review_of_the_research_report_2011_0.pdf.
Ray, W.A., Chung, C.P., Murray, K.T., Hall, K., & Stein, C.M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360(3), 225-235. doi: 10.1056/NEJMoa0806994.
Stachnik, J., & Nunn-Thompson, C. (2007). Use of atypical antipsychotics in the treatment of autistic disorder. Annals of Pharmacotherapy, 41(4), 626-634. doi: 10.1345/aph.1H527.
Weitlauf, A.S., McPheeters, M.L., Peters, B., Sathe, N., Travis, R., Aiello, R., Williamson, E., Veenstra-VanderWeele, J., Krishnaswami, S., Jerome, R., & Warren, Z. (2014). Therapies for children with autism spectrum disorder: Behavioral interventions update. Comparative Effectiveness Review no. 137 [AHRQ Publication No. 14-EHC036-EF]. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved 25 July 2016 from http://www.ncbi.nlm.nih.gov/books/NBK241444/.
Wong, C., Odom, S.L., Hume, K., Cox, A.W., Fettig, A., Kucharczyk, S., Brock, M.E., Plavnick, J.B., Fleury, V.P., & Schultz, T.R. (2014). Evidence-based practices for children, youth, and young adults with autism spectrum disorder. Chapel Hill, NC: University of North Carolina, Frank Porter Graham Child Development Institute, Autism Evidence-Based Practice Review Group. Retrieved 25 July 2016 from http://fpg.unc.edu/sites/fpg.unc.edu/files/resources/reports-and-policy-briefs/2014-EBP-Report.pdf.